Strides Pharma Science Limited — Board Meeting, 24-10-2024: Outcome of Board Meeting

Strides Pharma Science Limited reported un-audited financial results for the quarter and half-year ending September 30, 2024. Revenue from operations increased to ₹12,011.1 million from ₹10,875.05 million quarter-over-quarter. The company posted a profit after tax of ₹936.61 million compared to a loss of ₹1,494.55 million in the same quarter last year. It also announced an amalgamation with Strides Alathur Private Limited, effective April 1, 2023.